Abstract
Introduction: Burkitt lymphoma (BL) is a highly aggressive, though potentially curable, form of non-Hodgkin lymphoma. Despite achieving high cure rates in developed countries (90% among children and 60% among adults), it is associated with low survival in low-income countries (45% in Uganda, e.g.). Several chemotherapy regimens have been described, however, all contain drugs with signific…